Charles River Laboratories International, Inc.
CRL
Key stats
- Open
- 335.66
- Day high
- 342.83
- Day low
- 326.29
- Previous close
- 342.69
- Volume
- 902.1K
- VWAP
- 338.93
- 52-week high
- 379.63
- 52-week low
- 146.20
- Market cap
- 16.42B
- Shares out
- 47.92M
- Employees
- 19,700
- Listed
- 2000
About Charles River Laboratories International, Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · WILMINGTON, MA · criver.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 5.2K
- Put open interest
- 1.7K
- Put/call
- 0.32
- At-the-money IV
- 51.0%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 340 put | 9.80 | Nov 12, 3:02 PM | 102 | 54 | 53.4% |
| 280 call | 68.00 | Nov 2, 1:20 PM | 100 | 303 | 0.1% |
| 320 put | 3.35 | Nov 10, 3:59 PM | 66 | 87 | 52.5% |
| 370 put | 35.90 | Nov 2, 12:01 PM | 65 | 66 | 52.9% |
| 350 put | 17.70 | Nov 12, 10:45 AM | 50 | 122 | 51.4% |
| 370 call | 2.58 | Nov 11, 3:57 PM | 35 | 354 | 50.8% |
Quarterly results
Massive · Nov 4, 2026| Q3 2026 to Sep 26, 2026 | Q2 2026 to Jun 27, 2026 | Q1 2026 to Mar 28, 2026 | Q4 2025 to Dec 27, 2025 | |
|---|---|---|---|---|
| Revenue | $982.73M | $1.00B | $995.83M | $994.23M |
| Gross profit | $357.87M | $363.37M | $294.66M | $309.68M |
| Operating income | $202.64M | $119.89M | $119.90M | −$283.44M |
| Net income | $333.07M | −$1.48M | −$14.84M | −$276.56M |
| Diluted EPS | 6.86 | -0.03 | -0.30 | -5.68 |
| Operating cash flow | $254.09M | $179.72M | $41.08M | $147.52M |
| Assets | $7.45B | $7.53B | $7.73B | $7.14B |
| Liabilities | $4.18B | $4.64B | $4.74B | $3.92B |
| Equity | $3.23B | $2.85B | $2.95B | $3.17B |
Technicals
Massive · Nov 12, 2026- 50-day average310.17
- 200-day average227.08
- RSI (14 days)53.5
Short interest
Massive · Oct 30, 2026- Oct 30, 20262.99M shares · 2.2 days to cover
- Oct 15, 20262.83M shares · 2.9 days to cover
- Sep 30, 20262.88M shares · 2.7 days to cover
- Sep 15, 20262.23M shares · 2.8 days to cover
Related companies
MassiveNews coverage
No stories about Charles River Laboratories International, Inc. right now.